Usefulness of a liver biopsy in the evaluation of patients with elevated ALT values and serological markers of hepatitis viral infection an AIGO study

Digestive Diseases and Sciences

Volumn 46, Issue 7, 2001, Pages 1409-1415

  Andriulli, A ^a   Festa, V ^a   Leandro, G ^b   Rizzetto, M ^c,d  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b IRCCS   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

^d Associazione Italiana dei Gastroenterologi Ospedalieri   (Italy)

Author keywords

Aminotransferase; Chronic viral hepatitis; HBV; HCV; Hepatitis; Liver biopsy; Liver damage; Viruses

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERFERON;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL EXAMINATION; DIAGNOSTIC VALUE; DISEASE SEVERITY; HEPATITIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROLOGY;

ADULT; AGED; ALANINE TRANSAMINASE; BIOPSY; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; LIVER; MIDDLE AGED; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY;

EID: 0034933658     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010675401415     Document Type: Article

References (41)

1. Virus-host interactions in chronic hepatitis B virus infection
2. Hepatitis B virus infection
3. Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view
4. Hepatitis delta virus pathogenicity
5. Clinical virological and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B
6. Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment
7. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-α therapy
8. Treatment of chronic hepatitis D with interferon alfa-2b
9. Percutaneous biopsy in diffuse liver disease: Increasing diagnostic yield and decreasing complication rate by routine ultrasound assessment of puncture site
10. Histological grading and staging of chronic hepatitis
11. Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum transaminases
12. Evaluation of blood donors with elevated serum alanine amino-transferase levels
13. Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes?
14. Patients with persistent elevation of aminotransferases: Investigation with ultrasonography, radionuclide imaging and liver biopsy
15. Is hepatic ultrasonography a valid alternative tool to liver biopsy? Report on 507 cases studied with both techniques
16. Liver biopsy in the mid-1990s: Questions and answers
17. Predicting the liver histology in chronic hepatitis C: How good is the clinician?
18. The utility of liver biopsy (LBx) in diagnosis of hepatitis C (HCV)
19. Natural history of viral hepatitis, type C
20. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in Souythern Italy
21. The role of liver biopsy in hepatitis C
22. Hepatitis C viremia and liver disease in symptom-free individuals with anti-HCV
23. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels
24. The natural history of asymptomatic hepatitis B surface antigen carriers
25. Apporte de la biopsie hépatique et de la sérologie du virus de l'hépatite C au diagnostic d'une augmentation modérée et prolongée des aminotrasferases
26. Guidelines for the treatment of chronic viral hepatitis
27. Consensus development conference panel statement: Management of hepatitis C
28. Dépistage et traitement
29. Management of hepatitis C: A national survey of gastroenterologists and hepatologists
30. The diagnosis of cirrhosis: Clinical relevance and methodology
31. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy
32. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver
33. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy
34. Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective randomized trial
35. Percutaneous blind needle biopsy versus combined excisional and guided needle biopsy in the diagnosis of liver disorders in pediatric patients
36. Estimates of the cost-effectiveness of a 6 month course of interferon-α 2b in patients with histologically mild active hepatitis C
37. Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction
38. Recombinant alpha-interferon treatment of non A, and non B (type C) hepatitis: Review of studies and recommendations for treatment
39. Factors predicting early response to treatment with recombinant interferon-alpha 2a in chronic non-A, non B hepatitis
40. Interferon-alpha for chronic hepatitis C: An analysis of pre-treatment clinical predictors of response
41. Predictors of sustained response to alpha interferon therapy in chronic hepatitis C